Steven R. Patierno - Publications

Affiliations: 
The George Washington University, Washington, DC, United States 
Area:
Cell Biology, Oncology, Genetics

79 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Deveaux AE, Zhang D, Abo MA, Barrett NJ, Kittles RA, Owzar K, McCall SJ, Crawford J, Patierno SR, Clarke JM, Freedman JA. Abstract B071: Genomic differences between non-small cell lung cancer (NSCLC) in African American and white patients Cancer Epidemiology, Biomarkers & Prevention. 29. DOI: 10.1158/1538-7755.Disp18-B071  0.322
2018 Deveaux A, Wang B, Lacroix B, Patierno B, Zhang D, Owzar K, Lee N, George D, Freedman J, Patierno S. Abstract B59: Race-related differential splicing of the insulin receptor: A novel target underlying prostate cancer disparities Cancer Epidemiology, Biomarkers & Prevention. 27. DOI: 10.1158/1538-7755.Disp17-B59  0.316
2018 Patierno B, Glover W, Ribar T, Kittles R, Foo W, McCall S, Huang J, George D, Freedman J, Patierno S, Wood K, Hsu D. Abstract A79: Establishment of African American prostate cancer patient-derived primary cell lines and xenografts Cancer Epidemiology, Biomarkers & Prevention. 27. DOI: 10.1158/1538-7755.Disp17-A79  0.318
2018 LaCroix BL, Patierno BM, Sullenger BA, George DJ, Patierno SR, Freedman JA. Abstract SY45-02: Development of a novel therapeutic splice-switching oligonucleotide targeting race-related androgen receptor signaling and aggressive prostate cancer Cancer Epidemiology, Biomarkers & Prevention. 27. DOI: 10.1158/1538-7445.Am2018-Sy45-02  0.308
2017 Sauer SJ, Tarpley M, Shah I, Save AV, Lyerly HK, Patierno SR, Williams KP, Devi GR. Bisphenol A activates EGFR and ERK promoting proliferation, tumor spheroid formation and resistance to EGFR pathway inhibition in estrogen receptor-negative inflammatory breast cancer cells. Carcinogenesis. 38: 252-260. PMID 28426875 DOI: 10.1093/Carcin/Bgx003  0.343
2016 Ware KE, Somarelli JA, Schaeffer D, Li J, Zhang T, Park S, Patierno SR, Freedman J, Garcia-Blanco MA, Armstrong AJ. Snail promotes resistance to enzalutamide through regulation of androgen receptor activity in prostate cancer. Oncotarget. PMID 27409172 DOI: 10.18632/Oncotarget.10476  0.305
2013 Nickens KP, Wikstrom JD, Shirihai OS, Patierno SR, Ceryak S. A bioenergetic profile of non-transformed fibroblasts uncovers a link between death-resistance and enhanced spare respiratory capacity. Mitochondrion. 13: 662-7. PMID 24075934 DOI: 10.1016/J.Mito.2013.09.005  0.368
2012 Kost GC, Patierno SR, Wise SS, Holmes AL, Wise JP, Ceryak S. Protein tyrosine phosphatase (PTP) inhibition enhances chromosomal stability after genotoxic stress: decreased chromosomal instability (CIN) at the expense of enhanced genomic instability (GIN)? Mutation Research. 735: 51-5. PMID 22583656 DOI: 10.1016/J.Mrfmmm.2012.05.001  0.57
2012 Schneider BC, Constant SL, Patierno SR, Jurjus RA, Ceryak SM. Exposure to particulate hexavalent chromium exacerbates allergic asthma pathology. Toxicology and Applied Pharmacology. 259: 38-44. PMID 22178736 DOI: 10.1016/J.Taap.2011.12.001  0.406
2012 Nickens KP, Han Y, Shandilya H, Larrimore A, Gerard GF, Kaldjian E, Patierno SR, Ceryak S. Acquisition of mitochondrial dysregulation and resistance to mitochondrial-mediated apoptosis after genotoxic insult in normal human fibroblasts: a possible model for early stage carcinogenesis. Biochimica Et Biophysica Acta. 1823: 264-72. PMID 22057391 DOI: 10.1016/J.Bbamcr.2011.10.005  0.479
2012 Hopkins L, Forbes T, Schneider B, Constant SL, Leitenberg D, Schwartz AM, Patierno SR, Ceryak S. Abstract 5734: Role of the inflammasome complex in Cr(VI)-induced lung injury and inflammation Cancer Research. 72: 5734-5734. DOI: 10.1158/1538-7445.Am2012-5734  0.437
2012 Forbes TA, Hopkins L, Schneider B, Lazarus L, Leitenberg D, Constant S, Schwartz A, Patierno S, Ceryak S. Abstract 5456: Potential role of nitric oxide in chromium-induced lung carcinogenesis Cancer Research. 72: 5456-5456. DOI: 10.1158/1538-7445.Am2012-5456  0.452
2012 Gebreselassie D, Chun-Kost G, Saito E, Fernandez A, O'Brien T, Patierno SR, Ceryak SM. Abstract 2131: Plk1 decreases DNA double strand break (DSB) formation during replication- stalling genotoxic stress Cancer Research. 72: 2131-2131. DOI: 10.1158/1538-7445.Am2012-2131  0.561
2011 Gebreselassie D, Chun G, Saito E, Fernandez A, O'Brien T, Patierno SR, Ceryak S. Abstract 3914: Plk1 enhances DNA double strand break (DSB) repair during acute genotoxin exposure Cancer Research. 71: 3914-3914. DOI: 10.1158/1538-7445.Am2011-3914  0.803
2010 Wang BD, Kline CL, Pastor DM, Olson TL, Frank B, Luu T, Sharma AK, Robertson G, Weirauch MT, Patierno SR, Stuart JM, Irby RB, Lee NH. Prostate apoptosis response protein 4 sensitizes human colon cancer cells to chemotherapeutic 5-FU through mediation of an NF kappaB and microRNA network. Molecular Cancer. 9: 98. PMID 20433755 DOI: 10.1186/1476-4598-9-98  0.34
2010 Nickens KP, Patierno SR, Ceryak S. Chromium genotoxicity: A double-edged sword. Chemico-Biological Interactions. 188: 276-88. PMID 20430016 DOI: 10.1016/J.Cbi.2010.04.018  0.636
2010 Chun G, Bae D, Nickens K, O'Brien TJ, Patierno SR, Ceryak S. Polo-like kinase 1 enhances survival and mutagenesis after genotoxic stress in normal cells through cell cycle checkpoint bypass. Carcinogenesis. 31: 785-93. PMID 20089605 DOI: 10.1093/Carcin/Bgq014  0.77
2010 Bae D, Chun G, Patierno SR, Ceryak SM. Abstract LB-101: A novel role of semaphorin4a (sema4a) in genotoxin-induced DNA damage response in human lung fibroblasts Cancer Research. 70. DOI: 10.1158/1538-7445.Am10-Lb-101  0.815
2010 Savery LC, O'Brien TJ, Holmes AL, Wise JP, Patierno SR. Abstract 2978: Nucleotide excision repair contributes to hexavalent chromium-induced double strand breaks and chromosomal damage Cancer Research. 70: 2978-2978. DOI: 10.1158/1538-7445.Am10-2978  0.596
2010 Nickens KP, Han Y, Shandilya H, Gerard GF, Kaldjian EP, Wikstrom J, Shirihai O, Patierno S, Ceryak S. Abstract 122: Mitochondrial dysregulation and cellular death resistance in response to genotoxic stress Cancer Research. 70: 122-122. DOI: 10.1158/1538-7445.Am10-122  0.545
2009 Beaver LM, Stemmy EJ, Schwartz AM, Damsker JM, Constant SL, Ceryak SM, Patierno SR. Lung inflammation, injury, and proliferative response after repetitive particulate hexavalent chromium exposure. Environmental Health Perspectives. 117: 1896-902. PMID 20049209 DOI: 10.1289/Ehp.0900715  0.714
2009 O'Brien TJ, Witcher P, Brooks B, Patierno SR. DNA polymerase zeta is essential for hexavalent chromium-induced mutagenesis. Mutation Research. 663: 77-83. PMID 19428373 DOI: 10.1016/J.Mrfmmm.2009.01.012  0.835
2009 Lal MA, Bae D, Camilli TC, Patierno SR, Ceryak S. AKT1 mediates bypass of the G1/S checkpoint after genotoxic stress in normal human cells. Cell Cycle (Georgetown, Tex.). 8: 1589-602. PMID 19377290 DOI: 10.4161/Cc.8.10.8547  0.827
2009 Beaver LM, Stemmy EJ, Constant SL, Schwartz A, Little LG, Gigley JP, Chun G, Sugden KD, Ceryak SM, Patierno SR. Lung injury, inflammation and Akt signaling following inhalation of particulate hexavalent chromium. Toxicology and Applied Pharmacology. 235: 47-56. PMID 19109987 DOI: 10.1016/J.Taap.2008.11.018  0.787
2009 Bae D, Camilli TC, Chun G, Lal M, Wright K, O'Brien TJ, Patierno SR, Ceryak S. Bypass of hexavalent chromium-induced growth arrest by a protein tyrosine phosphatase inhibitor: enhanced survival and mutagenesis. Mutation Research. 660: 40-6. PMID 19013184 DOI: 10.1016/J.Mrfmmm.2008.10.006  0.857
2008 Brooks B, O'Brien TJ, Ceryak S, Wise JP, Wise SS, Wise JP, Defabo E, Patierno SR. Excision repair is required for genotoxin-induced mutagenesis in mammalian cells. Carcinogenesis. 29: 1064-9. PMID 18332048 DOI: 10.1093/Carcin/Bgn058  0.858
2006 Vilcheck SK, Ceryak S, O'Brien TJ, Patierno SR. FANCD2 monoubiquitination and activation by hexavalent chromium [Cr(VI)] exposure: activation is not required for repair of Cr(VI)-induced DSBs. Mutation Research. 610: 21-30. PMID 16893675 DOI: 10.1016/J.Mrgentox.2006.06.009  0.835
2006 O'Brien TJ, Jiang G, Chun G, Mandel HG, Westphal CS, Kahen K, Montaser A, States JC, Patierno SR. Incision of trivalent chromium [Cr(III)]-induced DNA damage by Bacillus caldotenax UvrABC endonuclease. Mutation Research. 610: 85-92. PMID 16890479 DOI: 10.1016/J.Mrgentox.2006.06.015  0.787
2005 Pritchard DE, Ceryak S, Ramsey KE, O'Brien TJ, Ha L, Fornsaglio JL, Stephan DA, Patierno SR. Resistance to apoptosis, increased growth potential, and altered gene expression in cells that survived genotoxic hexavalent chromium [Cr(VI)] exposure. Molecular and Cellular Biochemistry. 279: 169-81. PMID 16283527 DOI: 10.1007/S11010-005-8292-2  0.822
2005 Fornsaglio JL, O'Brien TJ, Patierno SR. Differential impact of ionic and coordinate covalent chromium (Cr)-DNA binding on DNA replication. Molecular and Cellular Biochemistry. 279: 149-55. PMID 16283524 DOI: 10.1007/S11010-005-8287-Z  0.848
2005 O'Brien TJ, Brooks BR, Patierno SR. Nucleotide excision repair functions in the removal of chromium-induced DNA damage in mammalian cells Molecular and Cellular Biochemistry. 279: 85-95. PMID 16283517 DOI: 10.1007/S11010-005-8225-0  0.854
2005 O'Brien TJ, Mandel HG, Sugden KD, Komarov AM, Patierno SR. Hypoxia impedes the formation of chromium DNA-adducts in a cell-free system. Biochemical Pharmacology. 70: 1814-22. PMID 16242673 DOI: 10.1016/J.Bcp.2005.09.016  0.592
2004 Ha L, Ceryak S, Patierno SR. Generation of S phase-dependent DNA double-strand breaks by Cr(VI) exposure: Involvement of ATM in Cr(VI) induction of γ-H2AX Carcinogenesis. 25: 2265-2274. PMID 15284180 DOI: 10.1093/Carcin/Bgh242  0.864
2004 Lugassy C, Kleinman HK, Engbring JA, Welch DR, Harms JF, Rufner R, Ghanem G, Patierno SR, Barnhill RL. Pericyte-like location of GFP-tagged melanoma cells: ex vivo and in vivo studies of extravascular migratory metastasis. The American Journal of Pathology. 164: 1191-8. PMID 15039208 DOI: 10.1016/S0002-9440(10)63207-5  0.304
2004 Xu J, Manning FC, O'Brien TJ, Ceryak S, Patierno SR. Mechanisms of chromium-induced suppression of RNA synthesis in cellular and cell-free systems: relationship to RNA polymerase arrest. Molecular and Cellular Biochemistry. 255: 151-60. PMID 14971656 DOI: 10.1023/B:Mcbi.0000007271.53241.Ae  0.508
2004 Ceryak S, Zingariello C, O'Brien T, Patierno SR. Induction of pro-apoptotic and cell cycle-inhibiting genes in chromium (VI)-treated human lung fibroblasts: lack of effect of ERK. Molecular and Cellular Biochemistry. 255: 139-49. PMID 14971655 DOI: 10.1023/B:Mcbi.0000007270.82431.3E  0.568
2003 O'Brien TJ, Ceryak S, Patierno SR. Complexities of chromium carcinogenesis: role of cellular response, repair and recovery mechanisms. Mutation Research. 533: 3-36. PMID 14643411 DOI: 10.1016/J.Mrfmmm.2003.09.006  0.645
2003 Rickles FR, Patierno S, Fernandez PM. Tissue factor, thrombin, and cancer. Chest. 124: 58S-68S. PMID 12970125 DOI: 10.1378/Chest.124.3_Suppl.58S  0.314
2003 Ha L, Ceryak S, Patierno SR. Chromium (VI) activates ataxia telangiectasia mutated (ATM) protein. Requirement of ATM for both apoptosis and recovery from terminal growth arrest Journal of Biological Chemistry. 278: 17885-17894. PMID 12637545 DOI: 10.1074/Jbc.M210560200  0.864
2002 Patierno SR, Manyak MJ, Fernandez PM, Baker A, Weeraratna AT, Chou DS, Szlyk G, Geib KS, Walsh C, Patteras J. Uteroglobin: a potential novel tumor suppressor and molecular therapeutic for prostate cancer. Clinical Prostate Cancer. 1: 118-24. PMID 15046703 DOI: 10.3816/Cgc.2002.N.014  0.322
2002 O'Brien TJ, Fornsaglio JL, Ceryak S, Patierno SR. Effects of hexavalent chromium on the survival and cell cycle distribution of DNA repair-deficient S. cerevisiae. Dna Repair. 1: 617-27. PMID 12509285 DOI: 10.1016/S1568-7864(02)00078-2  0.852
2002 Lugassy C, Haroun RI, Brem H, Tyler BM, Jones RV, Fernandez PM, Patierno SR, Kleinman HK, Barnhill RL. Pericytic-like angiotropism of glioma and melanoma cells. The American Journal of Dermatopathology. 24: 473-8. PMID 12454598 DOI: 10.1097/00000372-200212000-00003  0.301
2002 Vilcheck SK, O'Brien TJ, Pritchard DE, Ha L, Ceryak S, Fornsaglio JL, Patierno SR. Fanconi anemia complementation group A cells are hypersensitive to chromium(VI)-induced toxicity. Environmental Health Perspectives. 110: 773-7. PMID 12426130 DOI: 10.1289/Ehp.02110S5773  0.784
2002 O'Brien T, Mandel HG, Pritchard DE, Patierno SR. Critical role of chromium (Cr)-DNA interactions in the formation of Cr-induced polymerase arresting lesions. Biochemistry. 41: 12529-37. PMID 12369844 DOI: 10.1021/Bi020452J  0.815
2001 Pritchard DE, Ceryak S, Ha L, Fornsaglio JL, Hartman SK, O'Brien TJ, Patierno SR. Mechanism of apoptosis and determination of cellular fate in chromium(VI)-exposed populations of telomerase-immortalized human fibroblasts. Cell Growth & Differentiation : the Molecular Biology Journal of the American Association For Cancer Research. 12: 487-96. PMID 11682460  0.816
2001 O’Brien T, Xu J, Patierno SR. Effects of glutathione on chromium-induced DNA crosslinking and DNA polymerase arrest Molecular and Cellular Biochemistry. 222: 173-182. DOI: 10.1007/978-1-4615-0793-2_20  0.585
2000 Pritchard DE, Singh J, Carlisle DL, Patierno SR. Cyclosporin A inhibits chromium(VI)-induced apoptosis and mitochondrial cytochrome c release and restores clonogenic survival in CHO cells. Carcinogenesis. 21: 2027-33. PMID 11062164 DOI: 10.1093/Carcin/21.11.2027  0.769
2000 Attiga FA, Fernandez PM, Weeraratna AT, Manyak MJ, Patierno SR. Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases. Cancer Research. 60: 4629-37. PMID 10969817  0.753
2000 Waalkes MP, Fox DA, States JC, Patierno SR, McCabe MJ. Metals and disorders of cell accumulation: modulation of apoptosis and cell proliferation. Toxicological Sciences : An Official Journal of the Society of Toxicology. 56: 255-61. PMID 10910982 DOI: 10.1093/Toxsci/56.2.255  0.303
2000 Carlisle DL, Pritchard DE, Singh J, Patierno SR. Chromium(VI) induces p53-dependent apoptosis in diploid human lung and mouse dermal fibroblasts. Molecular Carcinogenesis. 28: 111-8. PMID 10900468 DOI: 10.1002/1098-2744(200006)28:2<111::Aid-Mc7>3.0.Co;2-Y  0.77
2000 Carlisle DL, Pritchard DE, Singh J, Owens BM, Blankenship LJ, Orenstein JM, Patierno SR. Apoptosis and P53 induction in human lung fibroblasts exposed to chromium (VI): effect of ascorbate and tocopherol. Toxicological Sciences : An Official Journal of the Society of Toxicology. 55: 60-8. PMID 10788560 DOI: 10.1093/Toxsci/55.1.60  0.815
2000 McLean JA, Acon BW, Montaser A, Singh J, Pritchard DE, Patierno SR. Determination of chromium in human lung fibroblast cells using a large bore-direct injection high-efficiency nebulizer with inductively coupled plasma mass spectrometry Applied Spectroscopy. 54: 659-663. DOI: 10.1366/0003702001950120  0.757
1999 Singh J, Pritchard DE, Carlisle DL, Mclean JA, Montaser A, Orenstein JM, Patierno SR. Internalization of carcinogenic lead chromate particles by cultured normal human lung epithelial cells: formation of intracellular lead-inclusion bodies and induction of apoptosis. Toxicology and Applied Pharmacology. 161: 240-8. PMID 10620481 DOI: 10.1006/Taap.1999.8816  0.8
1998 Singh J, McLean JA, Pritchard DE, Montaser A, Patierno SR. Sensitive quantitation of chromium-DNA adducts by inductively coupled plasma mass spectrometry with a direct injection high-efficiency nebulizer. Toxicological Sciences : An Official Journal of the Society of Toxicology. 46: 260-5. PMID 10048129 DOI: 10.1006/Toxs.1998.2512  0.776
1998 Bridgewater LC, Manning FCR, Patierno SR. Arrest of replication by mammalian DNA polymerases α and β caused by chromium-DNA lesions Molecular Carcinogenesis. 23: 201-206. PMID 9869448 DOI: 10.1002/(Sici)1098-2744(199812)23:4<201::Aid-Mc2>3.0.Co;2-6  0.439
1998 Singh J, Bridgewater LC, Patierno SR. Differential sensitivity of chromium-mediated DNA interstrand crosslinks and DNA-protein crosslinks to disruption by alkali and EDTA Toxicological Sciences. 45: 72-76. PMID 9848113 DOI: 10.1006/Toxs.1998.2489  0.472
1998 Singh J, Carlisle DL, Pritchard DE, Patierno SR. Chromium-induced genotoxicity and apoptosis: relationship to chromium carcinogenesis (review). Oncology Reports. 5: 1307-18. PMID 9769362 DOI: 10.3892/Or.5.6.1307  0.824
1997 Blankenship LJ, Carlisle DL, Wise JP, Orenstein JM, Dye LE, Patierno SR. Induction of apoptotic cell death by particulate lead chromate: differential effects of vitamins C and E on genotoxicity and survival. Toxicology and Applied Pharmacology. 146: 270-80. PMID 9344895 DOI: 10.1006/Taap.1997.8237  0.47
1996 Manning FC, Patierno SR. Apoptosis: inhibitor or instigator of carcinogenesis? Cancer Investigation. 14: 455-65. PMID 8816861 DOI: 10.3109/07357909609018903  0.453
1996 Xu J, Bubley GJ, Detrick B, Blankenship LJ, Patierno SR. Chromium(VI) treatment of normal human lung cells results in guanine-specific DNA polymerase arrest, DNA-DNA cross-links and S-phase blockade of cell cycle. Carcinogenesis. 17: 1511-7. PMID 8706257 DOI: 10.1093/Carcin/17.7.1511  0.522
1996 Costa M, Zhitkovich A, Gargas M, Paustenbach D, Finley B, Kuykendall J, Billings R, Carlson TJ, Wetterhahn K, Xu J, Patierno S, Bogdanffy M. Interlaboratory validation of a new assay for DNA-protein crosslinks. Mutation Research. 369: 13-21. PMID 8700178 DOI: 10.1016/S0165-1218(96)90043-9  0.411
1996 Mirsalis JC, Hamilton CM, O'Loughlin KG, Paustenbach DJ, Kerger BD, Patierno S. Chromium (VI) at plausible drinking water concentrations is not genotoxic in the in vivo bone marrow micronucleus or liver unscheduled DNA synthesis assays. Environmental and Molecular Mutagenesis. 28: 60-3. PMID 8698048 DOI: 10.1002/(Sici)1098-2280(1996)28:1<60::Aid-Em9>3.0.Co;2-I  0.323
1996 Bubley GJ, Xu J, Kupiec N, Sanders D, Foss F, O'Brien M, Emi Y, Teicher BA, Patierno SR. Effect of DNA conformation on cisplatin adduct formation. Biochemical Pharmacology. 51: 717-21. PMID 8615910 DOI: 10.1016/S0006-2952(95)02256-2  0.471
1995 Moody TW, Venugopal R, Zia F, Patierno S, Leban JJ, McDermed J. BW2258U89: A GRP receptor antagonist which inhibits small cell lung cancer growth Life Sciences. 56: 521-529. PMID 7869832 DOI: 10.1016/0024-3205(94)00481-7  0.32
1995 Stearns DM, Wise JP, Patierno SR, Wetterhahn KE. Chromium(III) picolinate produces chromosome damage in Chinese hamster ovary cells. The Faseb Journal. 9: 1643-1648. DOI: 10.1096/Fasebj.9.15.8529845  0.33
1994 Blankenship LJ, Manning FC, Orenstein JM, Patierno SR. Apoptosis is the mode of cell death caused by carcinogenic chromium. Toxicology and Applied Pharmacology. 126: 75-83. PMID 8184436 DOI: 10.1006/Taap.1994.1092  0.452
1994 Bridgewater LC, Manning FCR, Woo ES, Patierno SR. DNA polymerase arrest by adducted trivalent chromium Molecular Carcinogenesis. 9: 122-133. PMID 8142016 DOI: 10.1002/Mc.2940090304  0.457
1994 Xu J, Manning FC, Patierno SR. Preferential formation and repair of chromium-induced DNA adducts and DNA--protein crosslinks in nuclear matrix DNA. Carcinogenesis. 15: 1443-50. PMID 8033323 DOI: 10.1093/Carcin/15.7.1443  0.412
1994 Bridgewater LC, Manning FCR, Patierno SR. Base-specific arrest of in vitro DNA replication by carcinogenic chromium: Relationship to DNA interstrand crosslinking Carcinogenesis. 15: 2421-2427. PMID 7955085 DOI: 10.1093/Carcin/15.11.2421  0.459
1994 Wise JP, Stearns DM, Wetterhahn KE, Patierno SR. Cell-enhanced dissolution of carcinogenic lead chromate particles: the role of individual dissolution products in clastogenesis. Carcinogenesis. 15: 2249-54. PMID 7955062 DOI: 10.1093/Carcin/15.10.2249  0.38
1994 Manning FCR, Blankenship LJ, Wise JP, Xu J, Bridgewater LC, Patierno SR. Induction of internucleosomal DNA fragmentation by carcinogenic chromate: Relationship to DNA damage, genotoxicity, and inhibition of macromolecular synthesis Environmental Health Perspectives. 102: 159-167. PMID 7843091 DOI: 10.1289/Ehp.94102S3159  0.547
1993 Patierno SR, Dirscherl LA, Xu J. Transformation of rat tracheal epithelial cells to immortal growth variants by particulate and soluble nickel compounds. Mutation Research. 300: 179-93. PMID 7687017 DOI: 10.1016/0165-1218(93)90049-J  0.313
1993 Manning FC, Xu J, Patierno SR. Transcriptional inhibition by carcinogenic chromate: relationship to DNA damage. Molecular Carcinogenesis. 6: 270-9. PMID 1283064 DOI: 10.1002/Mc.2940060409  0.433
1992 Xu J, Wise JP, Patierno SR. DNA damage induced by carcinogenic lead chromate particles in cultured mammalian cells. Mutation Research. 280: 129-36. PMID 1378537 DOI: 10.1016/0165-1218(92)90008-N  0.446
1992 Wise JP, Leonard JC, Patierno SR. Clastogenicity of lead chromate particles in hamster and human cells. Mutation Research. 278: 69-79. PMID 1370121 DOI: 10.1016/0165-1218(92)90287-A  0.369
1989 Patierno SR, Sugiyama M, Costa M. Effect of nickel(II) on DNA-protein binding, thymidine incorporation, and sedimentation pattern of chromatin fractions from intact mammalian cells. Journal of Biochemical Toxicology. 2: 13-23. PMID 3508470 DOI: 10.1002/Jbt.2570020103  0.406
1989 Miura T, Patierno SR, Sakuramoto T, Landolph JR. Morphological and neoplastic transformation of C3H/10T1/2 Cl 8 mouse embryo cells by insoluble carcinogenic nickel compounds Environmental and Molecular Mutagenesis. 14: 65-78. PMID 2548861 DOI: 10.1002/Em.2850140202  0.346
1989 Patierno SR, Landolph JR. Soluble vs insoluble hexavalent chromate - Relationship of mutation to in vitro transformation and particle uptake Biological Trace Element Research. 21: 469-474. PMID 2484629 DOI: 10.1007/Bf02917290  0.338
1986 Patierno SR, Costa M. DNA-protein cross-links induced by nickel compounds in intact cultured mammalian cells. Chemico-Biological Interactions. 55: 75-91. PMID 4064195 DOI: 10.1016/S0009-2797(85)80121-6  0.479
Show low-probability matches.